7/31/26 17:13 | 9/4/25 | SLDB | Solid Biosciences Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ra Capital Management, L.P. | MA | DT | | 76 | P.dm | 1,823,326 | 12.28 | 0 | 148,528 | 115 | 277,189 | I | | | | | | | | | | | | | | |
6/15/26 16:30 | 6/11/26 | NDAQ | Nasdaq, Inc. | DE | Financ | FinTrd | Security & Commodity Brokers, | Investor Ab | | T | | 2 | P | 20,717 | 80.68 | 0 | 257 | 0 | 58,439 | I | | | | | | | | | | | | | | |
4/27/26 19:08 | 1/9/26 | LCTX | Lineage Cell Therapeutics, Inc. | CA | Health | BioPrd | Biological Products, (No Diag | Broadwood Partners, L.P. | NY | DT | | 35 | P.dm | 235,363 | 3.98 | 0 | 59,161 | 34 | 231,849 | M | | | | | | | | | | | | | | |
2/24/26 17:26 | 11/14/25 | SWX | Southwest Gas Holdings, Inc. | DE | Utility | NgDist | Natural Gas Transmission & Di | Icahn Carl C | FL | T | | 46 | P.m | 461,548 | 33.06 | 0 | 13,959 | 14 | 116,470 | I | | | | | | | | | | | | | | |
8/5/25 10:46 | 2/19/25 | CERE | Cerevel Therapeutics Holdings, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Perceptive Advisors LLC | NY | D | | 24 | P.dm | 215,270 | 6.73 | 0 | 31,978 | 55 | 90,485 | I | | | | | | | | | | | | | | |
10/20/23 18:27 | 10/18/23 | FYBR | Frontier Communications Parent, Inc. | DE | Financ | InvAdv | Investment Advice | Ares Management LLC | CA | T | | 97 | P.m | 400,320 | 11.88 | 0 | 33,698 | 55 | 94,742 | I | | | | | | | | | | | | | | |
9/21/23 17:15 | 9/19/23 | JYNT | Joint Corp | DE | Financ | Patent | Patent Owners & Lessors | Bandera Partners LLC | NY | T | | 17 | P.m | 16,613 | 10.74 | 0 | 1,546 | 65 | 3,937 | I | | | | | | | | | | | | | | |
2/22/23 17:39 | 2/17/23 | NSIT | Insight Enterprises Inc | DE | Retail | eCom | Catalog & Mail-Order Houses | Valueact Holdings, L.P. | CA | DTH | See Rema | 2 | P.m | 11,386 | 127.85 | 0 | 89 | 2 | 4,511 | I | | | | | | | | | | | | | | |
12/19/22 15:52 | 12/16/22 | BBSI | Barrett Business Services Inc | MD | BizSv | Staff | Help Supply Services | Justesen Jon L | WA | D | | 1 | P | 464 | 92.85 | 0 | 5 | 20 | 30 | D | | | | | | | | | | | | | | |